Renal biopsies of 69 patients with lupus nephritis were studied according to the WHO classification. The aim of the present study was to correlate the interstitial tryptase-positive mast cells with the interstitial TGF-β1 and α-SM actin expression and clinical outcome of lupus nephritis, and identify the pathological role of the interstitial tryptase-positive mast cells in lupus nephritis. The mean follow-up time was 70.7 ± 54.4 months. Eight patients were grouped as WHO class II lupus nephritis, 15 patients as class III, 28 patients as class IV and 18 patients as class V. Interstitial tryptase-positive mast cells were not correlated with clinical outcome and interstitial TGF-β1 expression in lupus nephritis. Interstitial tryptase-positive mast cells were correlated with tubulo-interstitial α-SM actin expression for WHO class V lupus nephritis, but not to the other classes. In conclusion, in spite of interstitial tryptase-positive mast cells being related to renal interstitial fibrosis process, their expression according to the clinical outcome of lupus nephritis was not significant.
D’Agati VD.Renal disease in systemic lupus erythematosus, mixed connective tissue disease, Sjogren’s syndrome and rheumatoid arthritis. In Jennette JC , Olson JL , Schwartz MM , Silva FG eds. Heptinstall’s pathology of the kidney, 5th edn, vol. I. Philadelphia: Lippincott-Raven , 1998: 541-599.
2.
Rahman MAA , Isenberg DA.Autoantibodies in lupus nephritis. In Lewis EJ , Schwartz MM , Korbet SM eds. Lupus nephritis. New York: Oxford University Press , 1999: 1-21.
3.
Razzaque MS , Taguchi T.Factors that influence and contribute to the regulation of fibrosis . Contrib Nephrol2003; 139: 1-11 .
4.
Wilson HM , Walbaum D , Rees AJ.Macrophages and the kidney . Curr Opin Nephrol Hypertens2004; 13: 285-290 .
5.
Kluth DC , Erwig LP , Rees AJ.Multiple facets of macrophages in renal injury . Kidney Int2004; 66: 542-557 .
6.
Ehara T , Shigematsu H.Mast cells in the kidney . Nephrology (Carlton)2003; 8: 130-138 .
7.
Eddy AA.Mast cells find their way to the kidney . Kidney Int2001; 60: 375-377 .
8.
Roberts IS , Brenchley PE.Mast cells: the forgotten cells of renal fibrosis . J Clin Pathol2000; 53: 858-862 .
9.
Hiromura K , Kurosawa M , Yano S , Naruse T.Tubulointerstitial mast cell infiltration in glomerulonephritis . Am J Kidney Dis1998; 32: 593-599 .
10.
Kondo S , Kagami S , Kido H , Strutz F , Muller GA , Kuroda Y.Role of mast cell tryptase in renal interstitial fibrosis . J Am Soc Nephrol2001; 12: 1668-1676 .
11.
Gruber BL.Mast cells in the pathogenesis of fibrosis . Curr Rheumatol Rep2003; 5: 147-153 .
12.
Jones SE , Kelly DJ , Cox AJ , Zhang Y , Gow RM , Gilbert RE.Mast cell infiltration and chemokine expression in progressive renal disease . Kidney Int2003; 64: 906-913 .
13.
Border WA , Noble NA.Transforming growth factor-β in tissue fibrosis . N Engl J Med1994; 331: 1286-1292 .
14.
Tamaki K , Okuda S.Role of TGF-beta in the progression of renal fibrosis . Contrib Nephrol2003; 139: 44-65 .
Moriyama T , Imai E.Role of myofibroblasts in progressive renal diseases . Contrib Nephrol2003; 139: 120-140 .
17.
Zhang G , Moorhead PJ , el Nahas M.Myofibrobalst and the progression of experimental glomerulonephritis . Exp Nephrol1995; 3: 308-318 .
18.
Ravinal RC , Costa RS , Coimbra TMet al.Classes, activity and chronicity indices, and alpha-smooth muscle actin expression as prognostic parameters in lupus nephritis outcome . Lupus2002; 11: 82-87 .
19.
Alpers CE , Hudkins KL , Gown AM , Johnson RJ.Enhanced expression of “muscle-specific” actin in glomerulonephritis . Kidney Int1992; 41: 1134-1142 .
20.
Johnson RJ , Floege J , Yoshimura A , Lida H , Couser WG , Alpers CE.The activated mesangial cell: a glomerular “myofibroblast”?J Am Soc Nephrol1992; 2: 190-197 .
21.
Najafi CC , Korbert SM , Lewis EJ , Schwartz MM , Reichlin M , Evans J.Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis . Kidney Int2001; 59: 2156-2163 .
22.
Kobert SM , Lewis EJ , Schwartz MM , Reichlin M , Evans J , Rohdes RD.Factors predictive of outcome in severe lupus nephritis . Am J Kidney Dis2000; 35: 904-914 .
23.
Appel GB , Silva F , Pirani CL , Meltzer JI , Estes D.Renal involvement in systemic lupus erythematosus: a survey of 56 patients emphasizing histologic classification . Medicine1978; 57: 371-410 .
24.
Appel GB , Cohen DJ , Pirani CL , Meltzer JI , Estes D.Long term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization . Am J Med1987; 83: 877-885 .
25.
Mitjavila F , Pac V , Moga I , Vidaller A , Carrera M , Pujol R.Clinico-pathological correlation and prognostic factors in lupus nephritis . Clin Exp Rheumatol1997; 15: 625-631 .
26.
Johnson J , Nived O , Sturfelt G.Outcome in systemic lupus nephritis: a prospective study of patients from defined population . Medicine1989; 68: 141-150 .
27.
Esdaile JM , Levington C , Federgreen W , Hayslet JP , Kashgarian M.The clinical and renal biopsy predictors of long-term outcome in lupus nephritis: a study of 87 patients and review of the literature . Q J Med1989; 72: 779-833 .
28.
Magil AB , Puterman ML , Ballon HSet al.Prognostic factors in diffuse proliferative lupus glomerulonephritis . Kidney Int1988; 34: 511-517 .
29.
McLaughlin J , Gladman DD , Urowitz MB , Bombardier C , Farewell VT , Cole E.Kidney biopsy in systemic lupus erythematosus. II. Survival analyses according to biopsy results . Arthritis Rheum1991; 34: 1268-1273 .
30.
Ehara T , Shigematsu H.Contribution of mast cells to the tubulointerstitial lesion in IgA nephritis . Kidney Int1998; 54: 1675-1683 .
31.
Kurusu A , Suzuki Y , Horikoshi S , Shirato I , Tomino Y.Relationship between mast cells in the tubulointerstitium and prognosis of patients with IgA nephropathy . Nephron2001; 89: 391-397 .
32.
Danilewicz M , Wagrowska-Danilewicz M.Quantitative analysis of interstitial mast cells in lupus and non-lupus membranous glomerulopathy . Pol J Pathol2001; 52: 211-217 .
33.
Danilewicz M , Wagrowska-Danilewicz M.Quantitative analysis of the interstitial mast cells in idiopathic mesangiocapillary glomerulonephritis type I . Nefrologia2001; 21: 253-259 .
34.
Danilewicz M , Wagrowska-Danilewicz M.Quantitative analysis of interstitial mast cells in AA and AL renal amyloidosis . Pathol Res Pract2002; 198: 413-419 .
35.
Danilewicz M , Wagrowska-Danilewicz M.Immunohistochemical analysis of the interstitial mast cells in acute rejection of human renal allografts . Med Sci Monit2004; 10: BR151-BR156 .
36.
Goto E , Honjo S , Yamashita H , Shomori K , Adachi H , Ito H.Mast cells in human allografted kidney: correlation with interstitial fibrosis . Clin Transplant2002; 16(Suppl 8): 7-11 .
37.
Otsubo S , Nitta K , Uchida K , Yumura W , Nihei H.Mast cells and tubulointerstitial fibrosis in patients with ANCA-associated glomerulonephritis . Clin Exp Nephrol2003; 7: 41-47 .
38.
Toth T , Toth-Jakatics R , Jimi S , Ihara M , Urata H , Takebayashi S.Mast cells in rapidly progressive glomerulonephritis . J Am Soc Nephrol1999; 10: 1498-1505 .
39.
Toth T , Toth-Jakatics R , Jimi S , Takebayashi S.Increased density of interstitial mast cells in amyloid A renal amyloidosis . Mod Pathol2000; 13: 1020-1028 .
40.
Pardo J , Diaz L , Errasti Pet al.Mast cells in chronic rejection of human renal allografts . Virchows Arch2000; 437: 167-172 .
41.
Solari V , Unemoto K , Piaseczna Piotrowska A , Puri P.Increased expression of mast cells in reflux nephropathy . Pediatr Nephrol2004; 19: 157-163 .
